aptivus 250 mg capsule molli
boehringer ingelheim (schweiz) gmbh - tipranavirum - capsule molli - tipranavirum 250 mg, ethanolum anhydricum 100 mg, propylenglycolum 73 mg, macrogolglyceroli ricinoleas 455 mg, glycerolorum octanoas/decanoas, trometamolum, aqua, e 310, kapselhülle: gelatina, propylenglycolum 107.1 mg, sorbitol sorbitan solution, glycerolum, e 171, e 172 (rubrum), drucktinte: propylenglycolum, e 172 (nigrum), polyvinylis acetas phtalas, macrogolum, pro capsula. - le infezioni da hiv - synthetika
sifrol er 0,375 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 0.375 mg corresp. pramipexolum 0.262 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
sifrol er 0,75 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 0.750 mg corresp. pramipexolum 0.524 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
sifrol er 1,5 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 1.500 mg corresp. pramipexolum 1.049 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
sifrol er 3,0 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 3.00 mg corresp. pramipexolum 2.097 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
sifrol er 4,5 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 4.500 mg corresp. pramipexolum 3.146 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
micardis amlo 40/5 mg compresse
boehringer ingelheim (schweiz) gmbh - telmisartanum, amlodipinum - compresse - telmisartanum 40 mg, amlodipinum 5 mg ut amlodipini besilas, natrii hydroxidum corresp. natrium 2.01 mg, povidonum k 25, megluminum, sorbitolum 168.64 mg, magnesii stearas, cellulosum microcristallinum, amylum pregelificatum, maydis amylum, silica colloidalis anhydrica, e 172 (nigrum), e 172 (flavum), e 133, pro compresso. - antihypertensivum - synthetika
micardis amlo 80/5 mg compresse
boehringer ingelheim (schweiz) gmbh - telmisartanum, amlodipinum - compresse - telmisartanum 80 mg, amlodipinum 5 mg ut amlodipini besilas, natrii hydroxidum corresp. natrium 4.02 mg, povidonum k 25, megluminum, sorbitolum 337.28 mg, magnesii stearas, cellulosum microcristallinum, amylum pregelificatum, maydis amylum, silica colloidalis anhydrica, e 172 (nigrum), e 172 (flavum), e 133, pro compresso. - antihypertensivum - synthetika
micardis amlo 80/10 mg compresse
boehringer ingelheim (schweiz) gmbh - telmisartanum, amlodipinum - compresse - telmisartanum 80 mg, amlodipinum 10 mg ut amlodipini besilas, natrii hydroxidum corresp. natrium 4.02 mg, povidonum k 25, megluminum, sorbitolum 337.28 mg, magnesii stearas, cellulosum microcristallinum, amylum pregelificatum, maydis amylum, silica colloidalis anhydrica, e 172 (nigrum), e 172 (flavum), e 133, pro compresso. - antihypertensivum - synthetika
pradaxa 75 mg capsule
boehringer ingelheim (schweiz) gmbh - dabigatranum etexilatum - capsule - dabigatranum etexilatum 75 mg ut dabigatrani etexilati mesilas 86.48 mg, acaciae gummi, acidum tartaricum, hypromellosum, dimeticonum, talcum, hydroxypropylcellulosum, kapselhülle: carrageenanum, hypromellosum, kalii chloridum, e 171, aqua purificata, drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, pro capsula. - prevenzione di ictus e embolia sistemica in pazienti adulti con fibrillazione atriale non valvolare. trattamento della trombosi venosa profonda e/o embolia polmonare. prevenzione della recidiva di trombosi venosa profonda e/o embolia polmonare. - synthetika